Logan Lutton

The FDA has approved Icotyde as the first and only IL-23R targeted oral peptide for the treatment of moderate-to-severe plaque psoriasis.

In Florida, abrupt cuts to HIV medication and insurance support are forcing patients off trusted regimens, exposing dangerous coverage gaps, and illustrating how policy decisions can quietly drive up both human and financial costs in the U.S. healthcare system.

A new research review suggests menopause may worsen obsessive-compulsive disorder symptoms for some women, with more than a quarter reporting increased severity during the transition.

The FDA has approved Cosentyx as the first interleukin-17A (IL-17A) inhibitor approved for pediatric hidradenitis suppurativa.

Women going through perimenopause who feel lonely and socially isolated are more likely to report memory and cognitive difficulties than those who report neither, with the highest risk seen in those experiencing both.

The FDA has approved Sotyktu (deucravacitinib) as the first selective TYK2 inhibitor for adults with active psoriatic arthritis.

A study published in Substance Use and Addiction found that combining nicotine replacement therapy with a rewards-based contingency management program helped people with HIV achieve higher short-term smoking cessation rates than nicotine replacement therapy alone.

Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 other states consider similar cuts amid rising program costs and stagnant federal funding.

A recent American Cancer Society study found that colorectal cancer is increasingly common, especially in adults under 50. Test your current knowledge with this slideshow and learn what you can be doing to prevent it.

UT Southwestern researchers found that testosterone may increase susceptibility to staph infections by activating bacterial communication pathways.

California health plans Blue Shield Promise and L.A. Care are partnering with the California Black Women’s Collective to help Black women in Los Angeles County gain career skills, mentorship and job opportunities through SheWorks California.

A RAND analysis finds that provisions in the One Big Beautiful Bill Act will reduce Medicaid funding to states by hundreds of billions of dollars over the next decade, driven largely by new work requirements and more frequent eligibility redeterminations that are projected to lower enrollment by millions.

Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure prophylaxis as a partial prevention strategy.

ViiV Healthcare unveiled new data at the Conference on Retroviruses and Opportunistic Infections on next-generation long-acting HIV therapies.

An abstract presented at CROI 2026 found that continuous Medicaid coverage during the COVID-19 public health emergency was associated with decreased dependence on AIDS Drug Assistance Programs.

Zimbabwe has become one of the first countries in the world to launch a national lenacapavir program, introducing the twice-yearly injectable HIV prevention drug as part of its ongoing efforts to reduce new infections and end AIDS as a public health threat.

In this video interview, Joseph Kleiman, president of Buzz Health, says that patients should always “do their homework” to see if they are paying the lowest possible price for their prescription, whether that’s through TrumpRx or another website.

A conversation with Joseph Kleiman emphasizes price transparency, consumer research and the need for consistent pricing and drug availability.

A study of older women suggests that greater muscle strength lowers the risk of death, regardless of other factors like sedentary behavior.

Citing updated scientific evidence, the FDA has revised safety labels for six menopause hormone therapies, removing previous boxed warnings to better reflect current understanding of their risks and benefits for women in early menopause

Aetna Medicaid and the National Association of Community Health Centers have partnered to reduce high blood pressure rates among Medicaid members in select states by expanding community-based care.

A conversation with Gil Yosipovitch, M.D., explores why itch worsens at night, how it rivals chronic pain in quality-of-life impact, and why better assessment of nighttime itch and sleep disruption is urgently needed.

Florida’s planned AIDS Drug Assistance Program cuts could strip more than 16,000 people of life-saving HIV medications, a move Colleen Kelley, M.D., M.P.H., warns will increase illness, deaths and HIV transmission while sowing fear among already vulnerable patients.

TrumpRx launched as a government-branded, direct-to-consumer discount platform for select brand-name drugs, but critics argue its cash-only savings may be limited, potentially misleading, and less cost-effective over time than traditional insurance or other programs.

Adolescent and young women are far less likely than men to receive HIV prevention medication despite meeting clinical eligibility and facing substantial HIV risk.

Massachusetts leads SmileHub’s women’s health ranking, revealing cost barriers, safety gaps and state policies that shape care and outcomes.

A large Korean, population-based study of more than 2 million women suggests that patterns across a woman’s reproductive life may influence ovarian cancer risk, with some factors increasing risk and others appearing protective.

The award will involve patients with chronic disease and their families to inform clinical research, with an initial focus on diabetes.